Need professional-grade analysis? Visit stockanalysis.com
$13.45B
N/A
1,151
1.14%
Vitrolife AB (VITR) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at SEK110.10, up 1.85% from the previous close.
Over the past year, VITR has traded between a low of SEK85.70 and a high of SEK161.50. The stock has lost 27.3% over this period. It is currently 31.8% below its 52-week high.
Vitrolife AB has a market capitalization of $13.45B and a dividend yield of 1.14%.
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
Side-by-side comparison against top Healthcare peers.